Bio-Medical Applications Of Alabama, Inc. is a medicare approved dialysis facility center in Birmingham, Alabama and it has 13 dialysis stations. It is located in Jefferson county at 9540 Parkway E, Birmingham, AL, 35215. You can reach out to the office of Bio-Medical Applications Of Alabama, Inc. at (205) 838-2652. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of Alabama, Inc. has the following ownership type - Profit. It was first certified by medicare in January, 2013. The medicare id for this facility is 012659 and it accepts patients under medicare ESRD program.
| Name | Bio-Medical Applications Of Alabama, Inc. |
|---|---|
| Location | 9540 Parkway E, Birmingham, Alabama |
| No. of Dialysis Stations | 13 |
| Medicare ID | 012659 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 9540 Parkway E, Birmingham, Alabama, 35215 | |
| (205) 838-2652 | |
News Archive
A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.
Cardiome Pharma Corp. today announced that its subsidiary, Cardiome International AG, has entered into an agreement with Algorithm S.A.L., headquartered in Beirut, Lebanon, to sell and distribute BRINAVESS (vernakalant intravenous) exclusively in certain Middle Eastern and North African countries.
Loyola University Chicago Stritch School of Medicine (SSOM) will receive the Moral Courage award from Faith in Public Life, a non-profit organization devoted to lifting up the voices of progressive faith leaders.
A team of researchers from the University of Houston (UH) and St. Luke's Episcopal Hospital (SLEH) are working to develop improved screening methods to detect a potentially lethal, drug-resistant superbug that has made its way to Texas.
› Verified 6 days ago
| NPI Number | 1346768603 |
| Organization Name | Fresenius Kidney Care Oak Mountain |
| Doing Business As | Bio-medical Applications Of Alabama, Inc. |
| Address | 105 Inverness Cors Birmingham, Alabama, 35242 |
| Phone Number | (205) 335-9098 |
News Archive
A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.
Cardiome Pharma Corp. today announced that its subsidiary, Cardiome International AG, has entered into an agreement with Algorithm S.A.L., headquartered in Beirut, Lebanon, to sell and distribute BRINAVESS (vernakalant intravenous) exclusively in certain Middle Eastern and North African countries.
Loyola University Chicago Stritch School of Medicine (SSOM) will receive the Moral Courage award from Faith in Public Life, a non-profit organization devoted to lifting up the voices of progressive faith leaders.
A team of researchers from the University of Houston (UH) and St. Luke's Episcopal Hospital (SLEH) are working to develop improved screening methods to detect a potentially lethal, drug-resistant superbug that has made its way to Texas.
› Verified 6 days ago
| NPI Number | 1598068660 |
| Organization Name | Fmc Of East Jefferson |
| Doing Business As | Bio-medical Applications Of Alabama, Inc. |
| Address | 9540 Parkway E Birmingham, Alabama, 35215 |
| Phone Number | (205) 838-2652 |
News Archive
A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.
Cardiome Pharma Corp. today announced that its subsidiary, Cardiome International AG, has entered into an agreement with Algorithm S.A.L., headquartered in Beirut, Lebanon, to sell and distribute BRINAVESS (vernakalant intravenous) exclusively in certain Middle Eastern and North African countries.
Loyola University Chicago Stritch School of Medicine (SSOM) will receive the Moral Courage award from Faith in Public Life, a non-profit organization devoted to lifting up the voices of progressive faith leaders.
A team of researchers from the University of Houston (UH) and St. Luke's Episcopal Hospital (SLEH) are working to develop improved screening methods to detect a potentially lethal, drug-resistant superbug that has made its way to Texas.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 30 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 27 |
News Archive
A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.
Cardiome Pharma Corp. today announced that its subsidiary, Cardiome International AG, has entered into an agreement with Algorithm S.A.L., headquartered in Beirut, Lebanon, to sell and distribute BRINAVESS (vernakalant intravenous) exclusively in certain Middle Eastern and North African countries.
Loyola University Chicago Stritch School of Medicine (SSOM) will receive the Moral Courage award from Faith in Public Life, a non-profit organization devoted to lifting up the voices of progressive faith leaders.
A team of researchers from the University of Houston (UH) and St. Luke's Episcopal Hospital (SLEH) are working to develop improved screening methods to detect a potentially lethal, drug-resistant superbug that has made its way to Texas.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 54 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 513 |
| Percentage of adult patients getting regular hemodialysis at the center | 94 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.
Cardiome Pharma Corp. today announced that its subsidiary, Cardiome International AG, has entered into an agreement with Algorithm S.A.L., headquartered in Beirut, Lebanon, to sell and distribute BRINAVESS (vernakalant intravenous) exclusively in certain Middle Eastern and North African countries.
Loyola University Chicago Stritch School of Medicine (SSOM) will receive the Moral Courage award from Faith in Public Life, a non-profit organization devoted to lifting up the voices of progressive faith leaders.
A team of researchers from the University of Houston (UH) and St. Luke's Episcopal Hospital (SLEH) are working to develop improved screening methods to detect a potentially lethal, drug-resistant superbug that has made its way to Texas.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of Alabama, Inc. with elevated calcium levels.
| Patients with hypercalcemia | 58 |
| Hypercalcemia patient months | 561 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 59 |
| Patients with Serumphosphor less than 3.5 mg/dL | 6 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 24 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 29 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 25 |
| Patients with Serumphosphor greater than 7 mg/dL | 15 |
News Archive
A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.
Cardiome Pharma Corp. today announced that its subsidiary, Cardiome International AG, has entered into an agreement with Algorithm S.A.L., headquartered in Beirut, Lebanon, to sell and distribute BRINAVESS (vernakalant intravenous) exclusively in certain Middle Eastern and North African countries.
Loyola University Chicago Stritch School of Medicine (SSOM) will receive the Moral Courage award from Faith in Public Life, a non-profit organization devoted to lifting up the voices of progressive faith leaders.
A team of researchers from the University of Houston (UH) and St. Luke's Episcopal Hospital (SLEH) are working to develop improved screening methods to detect a potentially lethal, drug-resistant superbug that has made its way to Texas.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 43 |
| Patient months included in arterial venous fistula and catheter summaries | 380 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 64 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 12 |
News Archive
A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.
Cardiome Pharma Corp. today announced that its subsidiary, Cardiome International AG, has entered into an agreement with Algorithm S.A.L., headquartered in Beirut, Lebanon, to sell and distribute BRINAVESS (vernakalant intravenous) exclusively in certain Middle Eastern and North African countries.
Loyola University Chicago Stritch School of Medicine (SSOM) will receive the Moral Courage award from Faith in Public Life, a non-profit organization devoted to lifting up the voices of progressive faith leaders.
A team of researchers from the University of Houston (UH) and St. Luke's Episcopal Hospital (SLEH) are working to develop improved screening methods to detect a potentially lethal, drug-resistant superbug that has made its way to Texas.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 53 |
| Hospitalization Rate in facility | 170.8 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 298.6 |
| Hospitalization Rate: Lower Confidence Limit | 101.6 |
News Archive
A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.
Cardiome Pharma Corp. today announced that its subsidiary, Cardiome International AG, has entered into an agreement with Algorithm S.A.L., headquartered in Beirut, Lebanon, to sell and distribute BRINAVESS (vernakalant intravenous) exclusively in certain Middle Eastern and North African countries.
Loyola University Chicago Stritch School of Medicine (SSOM) will receive the Moral Courage award from Faith in Public Life, a non-profit organization devoted to lifting up the voices of progressive faith leaders.
A team of researchers from the University of Houston (UH) and St. Luke's Episcopal Hospital (SLEH) are working to develop improved screening methods to detect a potentially lethal, drug-resistant superbug that has made its way to Texas.
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at Bio-Medical Applications Of Alabama, Inc. were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 25 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 38.1 |
| Readmission Rate: Lower Confidence Limit | 14.6 |
News Archive
A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.
Cardiome Pharma Corp. today announced that its subsidiary, Cardiome International AG, has entered into an agreement with Algorithm S.A.L., headquartered in Beirut, Lebanon, to sell and distribute BRINAVESS (vernakalant intravenous) exclusively in certain Middle Eastern and North African countries.
Loyola University Chicago Stritch School of Medicine (SSOM) will receive the Moral Courage award from Faith in Public Life, a non-profit organization devoted to lifting up the voices of progressive faith leaders.
A team of researchers from the University of Houston (UH) and St. Luke's Episcopal Hospital (SLEH) are working to develop improved screening methods to detect a potentially lethal, drug-resistant superbug that has made its way to Texas.
› Verified 6 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Bio-Medical Applications Of Alabama, Inc. get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.88 (As Expected) |
| SIR: Upper Confidence Limit | 3.9 |
| SIR: Lower Confidence Limit | .76 |
News Archive
A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.
Cardiome Pharma Corp. today announced that its subsidiary, Cardiome International AG, has entered into an agreement with Algorithm S.A.L., headquartered in Beirut, Lebanon, to sell and distribute BRINAVESS (vernakalant intravenous) exclusively in certain Middle Eastern and North African countries.
Loyola University Chicago Stritch School of Medicine (SSOM) will receive the Moral Courage award from Faith in Public Life, a non-profit organization devoted to lifting up the voices of progressive faith leaders.
A team of researchers from the University of Houston (UH) and St. Luke's Episcopal Hospital (SLEH) are working to develop improved screening methods to detect a potentially lethal, drug-resistant superbug that has made its way to Texas.
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Bio-Medical Applications Of Alabama, Inc.'s rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 44 |
| Transfusion Rate in facility | 44.4 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 123.2 |
| Transfusion Rate: Lower Confidence Limit | 18.2 |
News Archive
A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.
Cardiome Pharma Corp. today announced that its subsidiary, Cardiome International AG, has entered into an agreement with Algorithm S.A.L., headquartered in Beirut, Lebanon, to sell and distribute BRINAVESS (vernakalant intravenous) exclusively in certain Middle Eastern and North African countries.
Loyola University Chicago Stritch School of Medicine (SSOM) will receive the Moral Courage award from Faith in Public Life, a non-profit organization devoted to lifting up the voices of progressive faith leaders.
A team of researchers from the University of Houston (UH) and St. Luke's Episcopal Hospital (SLEH) are working to develop improved screening methods to detect a potentially lethal, drug-resistant superbug that has made its way to Texas.
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at Bio-Medical Applications Of Alabama, Inc. lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 199 |
| Mortality Rate in facility | 13.4 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 21.8 |
| Mortality Rate: Lower Confidence Limit | 7.7 |
News Archive
A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.
Cardiome Pharma Corp. today announced that its subsidiary, Cardiome International AG, has entered into an agreement with Algorithm S.A.L., headquartered in Beirut, Lebanon, to sell and distribute BRINAVESS (vernakalant intravenous) exclusively in certain Middle Eastern and North African countries.
Loyola University Chicago Stritch School of Medicine (SSOM) will receive the Moral Courage award from Faith in Public Life, a non-profit organization devoted to lifting up the voices of progressive faith leaders.
A team of researchers from the University of Houston (UH) and St. Luke's Episcopal Hospital (SLEH) are working to develop improved screening methods to detect a potentially lethal, drug-resistant superbug that has made its way to Texas.
› Verified 6 days ago
Birmingham East Dialysis Location: 1105 East Park Drive, Birmingham, Alabama, 35235 Phone: (205) 833-6003 |
News Archive
A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.
Cardiome Pharma Corp. today announced that its subsidiary, Cardiome International AG, has entered into an agreement with Algorithm S.A.L., headquartered in Beirut, Lebanon, to sell and distribute BRINAVESS (vernakalant intravenous) exclusively in certain Middle Eastern and North African countries.
Loyola University Chicago Stritch School of Medicine (SSOM) will receive the Moral Courage award from Faith in Public Life, a non-profit organization devoted to lifting up the voices of progressive faith leaders.
A team of researchers from the University of Houston (UH) and St. Luke's Episcopal Hospital (SLEH) are working to develop improved screening methods to detect a potentially lethal, drug-resistant superbug that has made its way to Texas.
› Verified 6 days ago